ATE103326T1 - Verfahren zur herstellung eines hochreinen thrombinkonzentrates. - Google Patents
Verfahren zur herstellung eines hochreinen thrombinkonzentrates.Info
- Publication number
- ATE103326T1 ATE103326T1 AT89122619T AT89122619T ATE103326T1 AT E103326 T1 ATE103326 T1 AT E103326T1 AT 89122619 T AT89122619 T AT 89122619T AT 89122619 T AT89122619 T AT 89122619T AT E103326 T1 ATE103326 T1 AT E103326T1
- Authority
- AT
- Austria
- Prior art keywords
- factor
- thrombin
- production
- high purity
- activation
- Prior art date
Links
- 108090000190 Thrombin Proteins 0.000 title abstract 4
- 229960004072 thrombin Drugs 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 239000012141 concentrate Substances 0.000 title 1
- 108010094028 Prothrombin Proteins 0.000 abstract 5
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 abstract 5
- 230000004913 activation Effects 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract 1
- 229910001424 calcium ion Inorganic materials 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3843126A DE3843126C3 (de) | 1988-12-22 | 1988-12-22 | Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates |
| EP89122619A EP0378798B1 (de) | 1988-12-22 | 1989-12-07 | Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE103326T1 true ATE103326T1 (de) | 1994-04-15 |
Family
ID=6369770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89122619T ATE103326T1 (de) | 1988-12-22 | 1989-12-07 | Verfahren zur herstellung eines hochreinen thrombinkonzentrates. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5143838A (esLanguage) |
| EP (1) | EP0378798B1 (esLanguage) |
| AT (1) | ATE103326T1 (esLanguage) |
| DE (2) | DE3843126C3 (esLanguage) |
| ES (1) | ES2051970T3 (esLanguage) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5281528A (en) * | 1989-12-18 | 1994-01-25 | Warner-Lambert Company | Process for purified thromboplastin for ultra-pure thrombin preparation |
| DE69130990T2 (de) * | 1990-02-20 | 1999-12-02 | Baxter International Inc., Deerfield | Gereinigtes, virusfreies menschliches Thrombin |
| DE69122376D1 (de) * | 1991-03-28 | 1996-10-31 | Warner Lambert Co | Hochreine Thrombinzubereitung |
| AT402891B (de) * | 1991-06-20 | 1997-09-25 | Immuno Ag | Verfahren zur herstellung eines inaktivierten blutproduktes |
| FR2679251B1 (fr) * | 1991-07-18 | 1993-11-12 | Nord Assoc Essor Transfusion San | Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique. |
| AT398079B (de) * | 1991-11-04 | 1994-09-26 | Immuno Ag | Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung |
| DE4137996A1 (de) * | 1991-11-19 | 1993-05-27 | Behringwerke Ag | Verfahren zur herstellung eines virussicheren thrombinkonzentrates |
| AT397390B (de) * | 1992-04-06 | 1994-03-25 | Immuno Ag | Verfahren zur spaltung von proteinen |
| US5792623A (en) * | 1992-04-06 | 1998-08-11 | Immuno Aktiengesellschaft | Method for producing activated blood factors with a protease and a detergent |
| AT399818B (de) * | 1992-04-24 | 1995-07-25 | Immuno Ag | Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation |
| DK83092D0 (da) * | 1992-06-24 | 1992-06-24 | Unes As | Fremgangsmaade til udvinding af thrombin |
| EP0674531A1 (de) * | 1992-12-16 | 1995-10-04 | IMMUNO Aktiengesellschaft | Verfahren zur herstellung eines virussicheren biologischen präparates |
| DE4242736A1 (de) * | 1992-12-17 | 1994-06-23 | Behringwerke Ag | Synthetische Peptide, Antikörper dagegen und ihre Verwendung |
| DE4320294A1 (de) * | 1993-06-18 | 1994-12-22 | Immuno Ag | Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen |
| US5795780A (en) * | 1993-06-23 | 1998-08-18 | Bristol-Myers Squibb Company | Method of use of autologous thrombin blood fraction in a cell culture with keratinocytes |
| JPH07308190A (ja) * | 1994-05-18 | 1995-11-28 | Green Cross Corp:The | トロンビンの製造方法 |
| US5506127A (en) * | 1994-09-21 | 1996-04-09 | Proba; Zbigniew | Therapeutic grade thrombin produced by chromatography |
| GB9503750D0 (en) * | 1995-02-24 | 1995-04-12 | Common Services Agency | Thrombin preparation |
| US5677162A (en) * | 1995-05-01 | 1997-10-14 | New York Blood Center, Inc. | Method for activating prothrombin to thrombin |
| AT404597B (de) * | 1995-11-24 | 1998-12-28 | Immuno Ag | Verfahren zur herstellung von proteinen |
| WO2000062828A1 (en) | 1996-04-30 | 2000-10-26 | Medtronic, Inc. | Autologous fibrin sealant and method for making the same |
| US6168788B1 (en) | 1997-09-26 | 2001-01-02 | Leon Wortham | Fibrin glue without fibrinogen and biosealant compositions and methods |
| US5981254A (en) * | 1997-10-30 | 1999-11-09 | Haemacure Corporation | Process for producing thrombin from plasma |
| US6274090B1 (en) | 1998-08-05 | 2001-08-14 | Thermogenesis Corp. | Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| US6472162B1 (en) | 1999-06-04 | 2002-10-29 | Thermogenesis Corp. | Method for preparing thrombin for use in a biological glue |
| GB0216002D0 (en) * | 2002-07-10 | 2002-08-21 | Nat Blood Authority | Process and composition |
| US7927626B2 (en) * | 2003-08-07 | 2011-04-19 | Ethicon, Inc. | Process of making flowable hemostatic compositions and devices containing such compositions |
| US8440225B2 (en) * | 2003-08-07 | 2013-05-14 | Ethicon, Inc. | Process of making flowable hemostatic compositions and devices containing such compositions |
| US20060019868A1 (en) * | 2004-01-30 | 2006-01-26 | Pendharkar Sanyog M | Hemostatic compositions and devices |
| US7109163B2 (en) * | 2004-01-30 | 2006-09-19 | Ethicon, Inc. | Hemostatic compositions and devices |
| EP2034010A1 (en) | 2007-08-30 | 2009-03-11 | Omrix Biopharmaceuticals Ltd. | Compositions suitable for repair and/or treatment of injured spinal tissue |
| WO2009109963A1 (en) | 2008-03-03 | 2009-09-11 | Omrix Biopharmaceuticals Ltd. | A gelatin sponge comprising an active ingredient, its preparation and use |
| EP2398394B1 (en) | 2009-02-20 | 2021-08-04 | Omrix Biopharmaceuticals Ltd. | Device for administering an at least two-component substance |
| JP5442310B2 (ja) * | 2009-04-23 | 2014-03-12 | 旭化成メディカル株式会社 | トロンビン溶液の調製方法 |
| AU2011210356B2 (en) * | 2010-01-28 | 2015-05-28 | Omrix Biopharmaceuticals Ltd. | Method for improved fibrin sealing |
| US9212357B2 (en) | 2012-12-03 | 2015-12-15 | Omrix Biopharmaceuticals Ltd. | Thrombin solution and methods of use thereof |
| IL230151A0 (en) | 2013-12-24 | 2014-09-30 | Omrix Biopharmaceuticals Ltd | One-component fibrin glue containing a polymerization inhibitor |
| IL231792A0 (en) | 2014-03-27 | 2014-08-31 | Omrix Biopharmaceuticals Ltd | Device and method for the preparation and administration of one-component fibrin glue |
| CN107406840B (zh) | 2015-02-25 | 2021-05-28 | 奥姆里克斯生物药品有限公司 | 用于纯化和定量凝血酶及其降解多肽的方法 |
| CN108660126A (zh) * | 2018-06-08 | 2018-10-16 | 博雅生物制药集团股份有限公司 | 一种冻干人凝血酶的制备工艺 |
| US12115356B2 (en) | 2019-03-06 | 2024-10-15 | Gambro Lundia Ab | Device and method for the delivery of a thrombin activated fibrin sealant |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2902158A1 (de) * | 1979-01-20 | 1980-07-31 | Biotest Serum Institut Gmbh | Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen |
| US4391746A (en) * | 1980-05-27 | 1983-07-05 | Cutter Laboratories, Inc. | Blood-coagulation-promoting products and methods of preparing them |
| US4364861A (en) * | 1980-05-27 | 1982-12-21 | Cutter Laboratories, Inc. | Blood-coagulation-promoting products and methods of preparing them |
| AT368883B (de) * | 1980-07-22 | 1982-11-25 | Immuno Ag | Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen |
| ATE20824T1 (de) * | 1981-06-25 | 1986-08-15 | Serapharm Gmbh & Co Kg | Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung. |
| US4380511A (en) * | 1981-08-12 | 1983-04-19 | Miles Laboratories, Inc. | Purification of bovine thrombin |
| ZA831399B (en) * | 1982-03-05 | 1984-02-29 | Health Lab Service Board | New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them |
| FR2527222A1 (fr) * | 1982-05-19 | 1983-11-25 | Christine Fougnot | Procede de separation et de purification des proteases et des antiproteases de la coagulation sanguine, ainsi que du complexe protease/antiprotease |
| US4639513A (en) * | 1984-02-02 | 1987-01-27 | Cuno Inc. | Intravenously injectable immunoglobulin G (IGG) and method for producing same |
| DE3430906A1 (de) * | 1984-08-22 | 1986-02-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur bestimmung von fibrinmonomer in plasma |
| US4965203A (en) * | 1987-01-28 | 1990-10-23 | Warner-Lambert Company | Purified thrombin preparations |
-
1988
- 1988-12-22 DE DE3843126A patent/DE3843126C3/de not_active Expired - Fee Related
-
1989
- 1989-12-07 AT AT89122619T patent/ATE103326T1/de not_active IP Right Cessation
- 1989-12-07 DE DE89122619T patent/DE58907303D1/de not_active Expired - Lifetime
- 1989-12-07 EP EP89122619A patent/EP0378798B1/de not_active Expired - Lifetime
- 1989-12-07 ES ES89122619T patent/ES2051970T3/es not_active Expired - Lifetime
- 1989-12-20 US US07/453,555 patent/US5143838A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE3843126A1 (de) | 1990-06-28 |
| DE3843126C3 (de) | 1994-10-06 |
| ES2051970T3 (es) | 1994-07-01 |
| EP0378798A1 (de) | 1990-07-25 |
| DE58907303D1 (de) | 1994-04-28 |
| EP0378798B1 (de) | 1994-03-23 |
| DE3843126C2 (esLanguage) | 1991-01-24 |
| US5143838A (en) | 1992-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE103326T1 (de) | Verfahren zur herstellung eines hochreinen thrombinkonzentrates. | |
| AU4251989A (en) | Method for the purification of proteins | |
| ES2155477T3 (es) | Purificacion cromatografica y procedimiento de separacion de acidos nucleicos. | |
| AU580494B2 (en) | Process for the extraction and purification of proteins from culture media producing them | |
| GB8906181D0 (en) | Process for the production of porous membranes,the membranes produced thereby and their use as supporting matrices in test strips | |
| AU581333B2 (en) | Method for anaerobic treatment of high strength liquors | |
| ATE19590T1 (de) | Verfahren zur herstellung des c1-inaktivators und seine verwendung. | |
| EP0208215A3 (en) | Purification of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices | |
| DE58907555D1 (de) | Verfahren zur Anreicherung der Blutgerinnungsfaktoren II, VII, IX und X. | |
| ATE2090T1 (de) | Verfahren zur herstellung eines plasminogenaktivators, so erhaltener aktivator und ihn enthaltendes arzneimittel. | |
| AU5565586A (en) | Improvements in or relating to a process for purifying proinsulin-like materials | |
| DE59000141D1 (de) | Verfahren zur isolierung des blutgerinnungsfaktors ix. | |
| ATE270327T1 (de) | Verfahren zur präparation von humanem aktiviertem protein c | |
| CA2213577A1 (en) | A process for the preparation of factor ix from biological sources | |
| SE7909897L (sv) | Rening av gammaglobulinderivat | |
| TW355706B (en) | A process for separating and purifying hydroxynaphthalene carboxylic acids | |
| ATE121644T1 (de) | Herstellung von permeablen hohlpartikeln. | |
| AU5595286A (en) | A process for the purification of plasmogen activators (PA) | |
| CA2026570A1 (en) | Method for Production and Purification of Hepatitis B Vaccine | |
| ATE36514T1 (de) | Verfahren zur herstellung von hydroxymethylcyclopropan (cyclopropylmethanol). | |
| Kuznetsov et al. | Polymeric adsorbents of the affinity type in the investigation of physiologically active substances II. New approches to the separation, isolation, and purification of hydroxycoumarins | |
| ATE198600T1 (de) | Verfahren zur reinigung von 11beta-21-dihydroxy- 2'-methyl-5'-betah-pregna-1,4-dieno(17,16-d)- oxazole-3, 20-dione | |
| JPS54107585A (en) | Preparation of pure heparitinase | |
| ES2127695A1 (es) | Procedimiento para la reduccion del contenido de factor plaquetar 4 en proteinas plasmaticas que poseen afinidad a heparina. | |
| KR970021092A (ko) | 트롬보모둘린의 정제 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEIH | Change in the person of patent owner | ||
| REN | Ceased due to non-payment of the annual fee |